Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravitreal drug therapy.

G A Peyman1, J A Schulman

  • 1LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans 70112.

Japanese Journal of Ophthalmology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of sensitivity to hyperbaric oxygen by CO2 in newborn rats.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·1995
Same author

Study of lymphocyte dynamics in the ocular circulation: technique of labeling cells.

Current eye research·1995
Same author

A practical guideline for management of endophthalmitis.

Ophthalmic surgery·1995
Same author

Direction and location of retinotomy for removal of subretinal neovascular membranes.

Ophthalmic surgery·1995
Same author

Posterior segment triple surgery after traumatic eye injuries.

Ophthalmic surgery·1995
Same author

Choroidal hyperpermeability in central serous choroidopathy: a new concept?

Archives of ophthalmology (Chicago, Ill. : 1960)·1995
Same journal

Correction: Clinical practice guideline for anterior segment dysgenesis.

Japanese journal of ophthalmology·2026
Same journal

Association between subjective symptoms and severity in patients with Fuchs endothelial corneal dystrophy.

Japanese journal of ophthalmology·2026
Same journal

Prevalence and clinical characteristics of Terson syndrome among survivors of aneurysmal subarachnoid hemorrhage: a nationwide study in Japan.

Japanese journal of ophthalmology·2026
Same journal

Epidemiology and treatment trends of retinopathy of prematurity: a multi-center study involving four Asian centers and one European center (2016-2023).

Japanese journal of ophthalmology·2026
Same journal

Clinical characteristics of angioid streaks in Japanese patients.

Japanese journal of ophthalmology·2026
Same journal

Preoperative risk factors for uncontrolled intraocular pressure after vitrectomy combined with intrascleral fixation of the intraocular lens.

Japanese journal of ophthalmology·2026
See all related articles

Poor drug penetration into the eye hinders ocular disorder treatment. This study reevaluates drug concentrations for intravitreal administration, especially in vitrectomized eyes, to improve treatment efficacy for conditions like endophthalmitis and retinitis.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Drug Delivery

Background:

  • The blood-ocular barrier, formed by retinal pigment epithelium and capillaries, limits drug entry into the eye.
  • Systemic drug administration is often ineffective for treating intraocular disorders due to this barrier.
  • Vitreous humor can impede drug diffusion towards the retina.

Purpose of the Study:

  • To determine safe and effective intravitreal drug doses for various ocular conditions.
  • To reevaluate drug concentrations for intravitreal use in vitrectomized eyes.
  • To assess the role of vitrectomy in treating infectious and inflammatory ocular diseases.

Main Methods:

  • Evaluation of nontoxic doses of antibiotics, antifungals, antivirals, antineoplastics, and anti-inflammatory agents.

Related Experiment Videos

  • Assessment of drug concentrations in vitrectomized eyes and vitrectomy infusion fluid.
  • Study of vitrectomy's role in managing bacterial and fungal endophthalmitis.

    • Main Results:

    • Established nontoxic intravitreal doses for a range of therapeutic agents.
    • Determined optimal drug concentrations for vitrectomized eyes and infusion fluids.
    • Defined the therapeutic role of vitrectomy in endophthalmitis treatment.

    Conclusions:

    • Intravitreal drug administration and vitrectomy are crucial for effectively treating severe ocular disorders.
    • Adjusting drug concentrations for vitrectomized eyes is necessary for optimal therapeutic outcomes.
    • Vitrectomy plays a significant role in managing infectious and inflammatory intraocular conditions.